Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oral verrucous carcinoma: a diagnostic and therapeutic challenge. | Radiol Oncol | 2023 | 36942907 | PubTator, text mining | PubMed |
| Paraneoplastic pemphigus and Castleman's disease: a case report and a revision of the literature. | Ital J Pediatr | 2023 | 36941723 | PubTator, text mining | PubMed |
| A primary cell-based in vitro model of the human small intestine reveals host olfactomedin 4 induction in response to Salmonella Typhimurium infection. | Gut Microbes | 2023 | 36939013 | PubTator, text mining | PubMed |
| DNA methylation differences in monozygotic twins with Van der Woude syndrome. | Front Dent Med | 2023 | 36936396 | PubTator, text mining | PubMed |
| Computer-aided classification of indirect immunofluorescence patterns on esophagus and split skin for the detection of autoimmune dermatoses. | Front Immunol | 2023 | 36926325 | PubTator, text mining | PubMed |
| Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis. | Sci Rep | 2023 | 36914702 | PubTator, text mining | PubMed |
| Aberrant splicing in human cancer: An RNA structural code point of view. | Front Pharmacol | 2023 | 36909167 | PubTator, text mining | PubMed |
| Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study. | BMC Gastroenterol | 2023 | 36906533 | PubTator, text mining | PubMed |
| Recent Advances on Cell Culture Platforms for In Vitro Drug Screening and Cell Therapies: From Conventional to Microfluidic Strategies. | Adv Healthc Mater | 2023 | 36898671 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma. | Saudi J Biol Sci | 2023 | 36879671 | PubTator, text mining | PubMed |
| B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy? | Front Immunol | 2023 | 36855629 | PubTator, text mining | PubMed |
| Case report: Vesiculobullous eruption with an atypical IgA deposition pattern in a patient with multiple myeloma-A case report and literature review. | Front Immunol | 2023 | 36845094 | PubTator, text mining | PubMed |
| Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients. | Sci Rep | 2023 | 36841845 | PubTator, text mining | PubMed |
| The dysregulation of circulating innate lymphoid cells is related to autoantibodies in pemphigus vulgaris. | Int Immunopharmacol | 2023 | 36841156 | PubTator, text mining | PubMed |
| Blood-Based Biomarkers for Eosinophilic Esophagitis and Concomitant Atopic Diseases: A Look into the Potential of Extracellular Vesicles. | Int J Mol Sci | 2023 | 36835081 | PubTator, text mining | PubMed |
| A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy. | Biomedicines | 2023 | 36830860 | PubTator, text mining | PubMed |
| Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma. | Cancer Manag Res | 2023 | 36824152 | PubTator, text mining | PubMed |
| Antibodies Against Glutamic Acid Decarboxylase 65 Are Locally Produced in the CSF and Arise During Affinity Maturation. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36823135 | PubTator, text mining | PubMed |
| Pemphigus Vulgaris Possibly Associated with COVID-19 Infection. | Cureus | 2023 | 36819405 | PubTator, text mining | PubMed |
| Post-Pemphigus Acanthomata Presenting as an Isolated, Hyperkeratotic Plaque. | Dermatopathology (Basel) | 2023 | 36810570 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers?page=18